Thiamine ( Intravenous Vitamin B1) induced post–operative analgesia in maxillofacial surgery.
Phase 2
- Conditions
- Maxillofacial surgery.00
- Registration Number
- IRCT201403061674N11
- Lead Sponsor
- Vice-Chancellery of Research and Technology, Shiraz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Inclusion criteria included: The patients with systemic disease and no history of drug use, and willingness to cooperate in this study are enrolled? Exclusion criteria included known allergy to the study drug, hepatic and renal dysfunction and lack of signed informed consent will be excluded.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intensity of postoperative pain. Timepoint: Immediately after surgery to 12 hours after surgery. Method of measurement: VAS.;Use of narcotic after surgery. Timepoint: To 12 hours after surgery. Method of measurement: Nursing reports.
- Secondary Outcome Measures
Name Time Method Post-operative complications of Thiamine. Timepoint: Immediately after surgery to 12 hours after surgery. Method of measurement: Nursing reports.;Patient's level of satisfaction. Timepoint: Immediately after surgery to 12 hours after surgery. Method of measurement: poor (0), moderate (1), good (2), and excellent (3).